TScan Therapeutics (TCRX) Selling, General & Administrative (2020 - 2026)
TScan Therapeutics' Selling, General & Administrative was $8.14 million in Q2 2026, down 10.5% from $9.1 million a year earlier and down 0.9% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Selling, General & Administrative (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, TScan Therapeutics' Selling, General & Administrative was $30.62 million through Jun 30, 2026, down 7.7% year-over-year; for FY2025, it was $31.99 million, up 5.6% from FY2024.
- Selling, General & Administrative has now increased for five consecutive years, with a five-year compound annual growth rate of 36.5% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $30.29 million in FY2024 (+14.9%), $26.35 million in FY2023 (+29.5%), $20.35 million in FY2022 (+47.2%) and $13.83 million in FY2021 (+105.1%).
- Quarterly Selling, General & Administrative has moved between $4.05 million (Q3 2021) and $9.1 million (Q2 2025) over five years.
- Compared with a year earlier, Selling, General & Administrative has declined for three straight quarters, with growth averaging 8.2% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 145.6%); the worst was Q4 2025 (a decline of 20.4%).
- Per Business Quant data, TCRX's Selling, General & Administrative in the three quarters before Q2 2026 was $8.22 million (Q1 2026), $6.39 million (Q4 2025) and $7.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | TScan Therapeutics | 41.58 Mn | 41.58 Mn | - | 8.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.14 Mn |
| Mar 31, 2026 | 8.22 Mn |
| Dec 31, 2025 | 6.39 Mn |
| Sep 30, 2025 | 7.87 Mn |
| Jun 30, 2025 | 9.10 Mn |
| Mar 31, 2025 | 8.63 Mn |
| Dec 31, 2024 | 8.02 Mn |
| Sep 30, 2024 | 7.41 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 7.08 Mn |
| Dec 31, 2023 | 6.16 Mn |
| Sep 30, 2023 | 5.89 Mn |
| Jun 30, 2023 | 6.53 Mn |
| Mar 31, 2023 | 7.77 Mn |
| Dec 31, 2022 | 6.14 Mn |
| Sep 30, 2022 | 4.91 Mn |
| Jun 30, 2022 | 4.81 Mn |
| Mar 31, 2022 | 4.49 Mn |
| Dec 31, 2021 | 4.45 Mn |
| Sep 30, 2021 | 4.05 Mn |
API Access
TScan Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();